OPTIGENEX INC has a total of 19 patent applications. It increased the IP activity by 900.0%. Its first patent ever was published in 1996. It filed its patents most often in United States, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and machines are PERNIX SLEEP INC, SOMAXON PHARMACEUTICALS INC and TREVI THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Russian Federation | 1 | |
#11 | Turkey | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Pero Ronald W | 7 |
#2 | Crouse Linda | 6 |
#3 | Giampapa Vincent C | 5 |
#4 | Linda Crouse | 4 |
#5 | Vincent C Giampapa | 4 |
#6 | Kraus Linda | 1 |
#7 | Dzhampapa Vinsent K | 1 |
#8 | Giampapa Vincent | 1 |
Publication | Filing date | Title |
---|---|---|
US10098922B1 | Increasing telomere length in a cell | |
US6964784B2 | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |